文献速递垂体与肾上腺疾病

先天性肾上腺皮质增生症儿童需要疾病特异性生长曲线

The Importance of Disease-specific Growth Charts for Children with Congenital Adrenal Hyperplasia.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

该研究基于两个大型临床数据库的515例经典CAH患者(0-20岁)的8692次随访数据,采用LMS半参数模型构建CAH特异性生长百分位曲线。结果显示CAH患者身高、体重、BMI的生长通道在整个生长期均与CDC参考显著不同,青春期突增减弱,且BMI的脂肪反弹提前(女性3.3岁,男性3.9岁)。结论强调需要CAH特异性生长曲线以辅助临床管理、评估生长轨迹及新疗法效果。

要点

  • CAH儿童身高、体重、BMI生长轨迹与正常人群显著不同。
  • CAH患者青春期突增减弱,脂肪反弹提前(女3.3岁,男3.9岁)。
  • 建议使用CAH特异性生长曲线评估生长和新疗法效果。

核心结论

  • CAH儿童在整个童年期的生长轨迹与未患病儿童存在特定差异,需要CAH特异性生长曲线辅助临床管理、生长轨迹评估及新疗法效果评价。

研究设计与样本

  • 回顾性分析两个大型临床数据库中0-20岁经典CAH患者的数据,共515例患者、8692次访视。
  • 采用LMS半参数建模方法生成0-20岁CAH特异性百分位曲线。
  • 采用单侧分位数检验进行节点分析,评估4、8、12、16、20岁时相对于CDC 2000标准图的增量生长差异,并通过曲线导数解估计脂肪反弹年龄。

主要发现

  • CAH患者的身高、体重、BMI生长通道在整个生长期与CDC参考显著不同。
  • CAH患者青春期突增相对于CDC参考减弱。
  • 基于BMI的脂肪反弹启动时间在CAH患者中更早:女性3.3岁,男性3.9岁,而正常对照为5-8岁。

关键数值与推荐

  • 脂肪反弹年龄:CAH女性3.3岁,男性3.9岁;正常对照5-8岁。

临床怎么用

  • 临床管理CAH儿童生长时,应使用CAH特异性生长曲线而非普通人群曲线。
  • 可利用CAH特异性曲线评估生长轨迹及新疗法的效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Children with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency typically have height, weight, and body mass index (BMI) growth patterns that differ from the general population due to increased androgen and/or glucocorticoid exposures. With the recent surge in the development of new therapies, CAH-specific growth charts are needed to evaluate the effectiveness of these new treatments. METHODS: Retrospective data from patients aged 0 to 20 years with classic CAH, confirmed by hormonal testing and/or CYP21A2 genotyping, from 2 large clinical databases were analyzed. Specialized charts were developed using the lamda-mu-sigma semiparametric modeling method to generate CAH-specific percentile curves from 0 to 20 years. Nodal-point analyses were conducted to assess differences in incremental growth at 4, 8, 12, 16, and 20 years of age relative to Centers for Disease Control and Prevention (CDC) 2000 normative charts using 1-sided quantile tests and age of adiposity rebound estimated with curve derivative solutions. RESULTS: A total sample of 8692 visits from 515 patients was used. Growth (height-, weight-, BMI-for-age) channels of CAH patients were significantly different over the entire growing period and characterized by diminished pubertal spurt relative to the CDC reference. Onset of adiposity rebound based on BMI-for-age occurred earlier for CAH patients (females 3.3 years, males 3.9 years) compared to their normative counterparts (5-8 years). CONCLUSION: Our study showed that at incremental time points throughout childhood, children with CAH collectively follow specific differences in growth trajectories as compared to unaffected children. These variations highlight the need for CAH-specific charts to assist in clinical management, appraisal of growth trajectories, and assessment of the impact of new therapies.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Sarafoglou K, Mercado Munoz Y, Sukin C, et al. The Importance of Disease-specific Growth Charts for Children with Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab. 2026. PMID: 41052298. doi:10.1210/clinem/dgaf554

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。